An improvement of the safety profile of SARS-CoV-2 vaccines is desirable
- PMID: 39263854
- PMCID: PMC11391212
- DOI: 10.1002/prp2.70008
An improvement of the safety profile of SARS-CoV-2 vaccines is desirable
Keywords: Guillain‐Barre syndrome; SARS‐CoV‐2 vaccination; VITT; adverse reactions; side effects.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Similar articles
-
Association between covid-19 vaccination, SARS-CoV-2 infection, and risk of immune mediated neurological events: population based cohort and self-controlled case series analysis.BMJ. 2022 Mar 16;376:e068373. doi: 10.1136/bmj-2021-068373. BMJ. 2022. PMID: 35296468 Free PMC article.
-
SARS-CoV-2 infection confers greater immunity than shots.Science. 2021 Sep 3;373(6559):1067-1068. doi: 10.1126/science.acx8993. Epub 2021 Sep 1. Science. 2021. PMID: 34516858 No abstract available.
-
Guillain-Barre syndrome should be monitored upon mass vaccination against SARS-CoV-2.Hum Vaccin Immunother. 2021 Sep 2;17(9):2957-2958. doi: 10.1080/21645515.2021.1922061. Epub 2021 May 25. Hum Vaccin Immunother. 2021. PMID: 34032555 Free PMC article.
-
[Vaccination immunology in SARS-CoV-2].Ugeskr Laeger. 2021 Mar 15;183(11):V02210120. Ugeskr Laeger. 2021. PMID: 33734074 Review. Danish.
-
Leveraging on the genomics and immunopathology of SARS-CoV-2 for vaccines development: prospects and challenges.Hum Vaccin Immunother. 2021 Mar 4;17(3):620-637. doi: 10.1080/21645515.2020.1812313. Epub 2020 Sep 16. Hum Vaccin Immunother. 2021. PMID: 32936732 Free PMC article. Review.
References
-
- Algahtani HA, Shirah BH, Albeladi YK, Albeladi RK. Guillain‐Barré syndrome following the BNT162b2 mRNA COVID‐19 vaccine. Acta Neurol Taiwanica. 2023;32(2):82‐85. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous